Lichtdermatosen

Widmung

Herrn Prof. Dr. med. habil. Lutz Kowalzick gewidmet.

Zusammenfassung

Der Begriff Lichtdermatosen beschreibt eine heterogene Gruppe von Hauterkrankungen, die durch die Einwirkung von ultravioletter oder sichtbarer Sonnenstrahlung ausgelöst oder verschlimmert wird [1]. Echte Lichtdermatosen sind Krankheiten, die durch abnormale Reaktionen auf Sonnenlicht verursacht werden. Ungewöhnliche Reaktionen wie diese müssen von gewöhnlichen Reaktionen auf Sonnenlicht wie Sonnenbrand unterschieden werden [2]. Photodermatosen betreffen Menschen in jeder Altersgruppe. Eine oft schwierige Diagnosesicherung ist wichtig, um mit präziser Therapie den jeweils individuellen Sonnenschutz zu erreichen.

Mit der Einteilung von primären und sekundären Lichtdermatosen werden grundsätzlich auch akute und chronische Verlaufsformen unterschieden. Primäre Lichtdermatosen sind eine eigene Krankheitsentität und werden durch photosensibilisierende Substanzen hervorgerufen. Bei unbekannter Ätiologie spricht man von idiopathischen primären Lichtdermatosen. Die sekundären Lichtdermatosen sind die Folge von anderen Grunderkrankungen, z.B. von Stoffwechselerkrankungen oder Gendefekten [3].

Mit dem folgenden Artikel soll dem Leser zu einem besseren Verständnis von Diagnostik und Therapie der primären Lichtdermatosen verholfen werden.

Abstract

The term photodermatoses describes a heterogeneous group of skin diseases that are triggered or aggravated by exposure to ultraviolet or visible solar radiation [1]. True photodermatoses are caused by abnormal reactions to sunlight. Unusual reactions such as these must be distinguished from common reactions to sunlight such as sunburn [2]. Photodermatoses affect people in every age group. The diagnosis is often difficult and is important in order to achieve individual sun protection and precise therapy.

The classification is in primary and secondary photodermatoses, and acute and chronic form. Primary photodermatoses are a separate disease entity and are caused by photosensitizing substances. If the etiology is unknown, it is referred to as idiopathic primary photodermatoses. Secondary photodermatoses are the result of other underlying diseases, e.g. metabolic diseases or genetic defects [3].

The following article is intended to help the reader to became better understanding of the diagnosis and treatment of primary photodermatoses.

Publication History

Article published online:
14 June 2024

• Literatur

• 1 Beattie PE. et al. Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases. Arch Dermatol 2003; 139: 1149-1154 DOI: 10.1001/archderm.139.9.1149. (PMID: 12975156)
• 2 Botto NC, Warshaw EM. Solar urticaria. J Am Acad Dermatol 2008; 59: 909-920 DOI: 10.1016/j.jaad.2008.08.020. (PMID: 19022098)
• 3 Combalia A, Fernández-Sartorio C, Fustà X. et al. Successful Short Desensitization Treatment Protocol with Narrowband UVB Phototherapy (TL-01) in Polymorphic Light Eruption. Actas Dermosifiliogr 2017; 108: 752-757
• 4 Duhovic C. et al. Detecting photoallergic contact dermatitis with patch testing and daylight. Contact Dermatitis 2018; 78: 85-86
• 5 Du-Thanh A. et al. Solar urticaria: a time-extended retrospective series of 61 patients and review of literature. Eur J Dermatol 2013; 23: 202-207 DOI: 10.1684/ejd.2013.1933. (PMID: 23587746)
• 6 Durbec F, Reguiaï Z, Léonard F. et al. Efficacy of ω-3 polyunsaturated fatty acids for the treatment of refractory hydroa vacciniforme. Pediatr Dermatol 2012; 29: 118-119 DOI: 10.1111/j.1525-1470.2011.01486.x. (PMID: 21967631)
• 7 Grossberg AL. Update on pediatric photosensitivity disorders. Curr Opin Pediatr 2013; 25: 474-479 DOI: 10.1097/MOP.0b013e328362c2c3. (PMID: 23817304)
• 8 Gruber-Wackernagel A, Hofer A, Legat F. et al. Frequency of occurrence of polymorphic light eruption in patients treated with photohardening and patients treated with phototherapy for other diseases. Photodermatol Photoimmunol Photomed 2019; 35: 100-105
• 9 Gupta G, Man I, Kemmett D. Hydroa vacciniforme: A clinical and follow-up study of 17 cases. J Am Acad Dermatol 2000; 42: 208-213 DOI: 10.1016/S0190-9622(00)90127-0. (PMID: 10642674)
• 10 Hamada T, Aoyama Y, Shirafuji Y. et al. Phenotypic analysis of circulating T-cell subset and its association with burden of skin disease in patients with chronic actinic dermatitis: a hematologic and clinicopathologic study of 20 subjects. Int J Dermatol 2017; 56: 540-546
• 11 Jones AC, McGuff HS, Huber M. Oral and Maxillofacial Pathology. Case of the Month. Actinic prurigo. Tex Dent J 2015; 132: 168-169 (PMID: 26234110)
• 12 Kowalzik L. Omalizumab zur Therapie der Lichturtikaria: noch viele offene Fragen. Allergo J Int 2016; 25: 16-17
• 13 Lehmann P, Schwarz T. Photodermatoses: diagnosis and treatment. Dtsch Arztebl Int 2011; 108: 135-141 DOI: 10.3238/arztebl.2011.0135. (PMID: 21442060)
• 14 Kowalzick L. Praxis der Lichtdermatosen. Diagnostik, Therapie und Prävention. 1. Auflage. Bremen: Uni-Med Verlag; 2000
• 15 Kowalzick L. Sommerdermatosen durch UV-Strahlung. Akt Dermatol 2007; 33: 289
• 16 Lehmann P. Photodermatoses – diagnosis and treatment. Dtsch Med Wochenschr 2004; 129: 259-266 DOI: 10.3238/arztebl.2011.0135. (PMID: 21442060)
• 17 Ling TC, Clayton TH, Crawley J. et al. British association of dermatologists and british photodermatology group guidelines for the safe and effective use of psoralen-ultraviolet A therapy. Br J Dermatol 2016; 174: 24-55 DOI: 10.1111/bjd.14317. (PMID: 26790656)
• 18 Monteiro AF. et al. Drug-induced photosensitivity: Photoallergic and phototoxic reactions. Clin Dermatol 2016; 34: 571-581 DOI: 10.1016/j.clindermatol.2016.05.006. (PMID: 27638435)
• 19 Mahler V. Kontaktekzeme. Akt Dermatol 2015; 40: 95-107
• 20 Oakley AM, Ramsey ML. Polymorphic Light Eruption. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK430886/
• 21 Naka F, Shwayder T, Santoro F. Photodermatoses: Kids are not just little people. Clinics in Dermatology 2016; 34: 724-735
• 22 Iwatsuki K, Satoh M, Yamamoto T. et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006; 142: 587-595
• 23 O'Gorman SM. et al. Photoaggravated disorders. Dermatol Clin 2014; 32: 385-398 DOI: 10.1016/j.det.2014.03.008. (PMID: 24891060)
• 24 Paek SY. et al. Chronic actinic dermatitis. Dermatol Clin 2014; 32: 355-361 DOI: 10.1016/j.det.2014.03.007. (PMID: 24891057)
• 25 Santoro FA, Lim HW. Update on photodermatoses. Semin Cutan Med Surg 2011; 30: 229-238 DOI: 10.1016/j.sder.2011.07.007. (PMID: 22123421)
• 26 Pile HD, Crane JS. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK499957/
• 27 Plaza JA, Toussaint S, Prieto VG. et al. Actinic Prurigo Cheilitis: A Clinicopathologic Review of 75 Cases. Am J Dermatopathol 2016; 38: 418-422 DOI: 10.1097/DAD.0000000000000459. (PMID: 26981737)
• 28 Quintanilla-Martinez L, Fend F. Deciphering hydroa vacciniforme. Blood 2019; 133: 2735-2737 DOI: 10.1182/blood.2019001031. (PMID: 31248873)
• 29 Rice A, Bermudez R. Hydroa Vacciniforme. Treasure Island (FL): StatPearls Publishing; 2022
• 30 Sangueza M, Plaza JA. Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases. J Am Acad Dermatol 2013; 69: 112-119 DOI: 10.1016/j.jaad.2013.01.037. (PMID: 23541598)
• 31 Yashar SS, Lim HW. Classification and evaluation of photodermatoses. Dermatol Ther 2003; 16: 1-7 DOI: 10.1046/j.1529-8019.2003.01601.x. (PMID: 12919120)
• 32 Schwarz T. Schnellabhärtung mit UVA1 – ein neues Therapieverfahren der Urticaria solaris. Akt Dermatol 2004; 30: 55-58
• 33 Niebel D, Vos L de, Fetter T. et al. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions. Am J Clin Dermatol 2023; 24: 521-540 DOI: 10.1007/s40257-023-00774-8. (PMID: 37140884)